Close icon

Personalise what you see on this page.

Choose from the options below. We'll show you information based on your current location as default.

I'M FROM

  • United States
Please select so we can show the most relevant content.

LIVING IN

  • United States
Please select so we can show the most relevant content.

LOOKING FOR

  • Undergraduate courses
Please select so we can show the most relevant content.

Change here for Clearing courses

Viewing as a student from United States living in United States interested in Undergraduate courses

You are looking at:

Courses starting in 2022

OK, GOT IT

Looking for Clearing information?

CHANGE

MSc Cancer Immunotherapy with Placement Year

University of Hertfordshire

Add to favourites

Course options

  • Qualification

    MSc - Master of Science

  • Location

    University of Hertfordshire

  • Study mode

    Sandwich / Placement

  • Start date

    21-SEP-21, 21-SEP-22

  • Duration

    2 years

Course summary

About the course

The use of the immune system in cancer therapy is a prevailing ambition in the field. You’ll gain expert knowledge of the numerous ways cancers and the immune system interact so you can learn how cancer immunotherapies are developed. We’ll provide a thorough understanding of immune effector mechanisms and cancer biology. You’ll develop a range of personal skills through self-directed learning and our problem-based approach to teaching.

Why choose this course?

  • You’ll be taught by our expert staff and innovative speakers from the biopharmaceutical industry.
  • Our modern Science Building provides excellent facilities for laboratory experiments, including DNA and genomic analysis eg QPCR, protein and proteomic science (eg MALDI-ToF), cell culture and Enzyme-based assays, isolated tissue studies and immunohistochemistry
  • When you graduate, you’ll be equipped to work in a broad range of fields including medical or pharmaceutical research and development, clinical trials, public health and epidemiology, academia research, medical writing and science journalism, education, or patent law
  • We adopt a blended learning approach to teaching, focussing on problem-based scenarios so you can develop strong critical analysis skills. You’ll benefit from exposure to practical techniques and guaranteed laboratory-based research projects
  • If successful you will have the opportunity to apply for a 12-month placement. If you are not successful in finding placement position then you can transfer to MSc Cancer Immunotherapy Advanced Research route.

What will I study?

You’ll benefit from the research interests of the Bioscience Research Group. These include studies of the tumour microenvironment and communication with infiltrating immune cells, the methods tumours employ to diminish the effectivity of immune effector mechanisms and how tumours communicate using extracellular vesicles with pre-metastatic sites. We’ll cover topics such as adoptive T cell therapy, tumour-associated macrophages, NK cells, monoclonal antibodies in cancer therapy, vaccines, microbial cancer therapies and immune checkpoint blockade.

Teaching will be delivered through lectures, tutorials and practical classes. You’ll immerse yourself in a research project which utilises problem-based and self-directed learning. You’ll explore case studies to gain a strong critical understanding. Through your research projects, carried out in our innovative Science Building and supervised by world-leading researchers, you’ll be trained in data collection, analysis and its interpretation. You’ll also benefit from expert external speakers from the biopharmaceutical industry.

Tuition fees

Students living in United States
(international fees)

£ 13,500per year

Tuition fees shown are for indicative purposes and may vary. Please check with the institution for most up to date details.

University information

University of Hertfordshire

  • University League Table

    80th

  • Campus address

    University of Hertfordshire, College Lane, Hatfield, Hertfordshire, AL10 9AB, England

Is this page useful?

Yes No

Sorry about that...

HOW CAN WE IMPROVE IT?

SUBMIT

Thanks for your feedback!